Cost-effectiveness of dialectical behavioural therapy versus treatment as usual for autism with suicidal behaviours: single-blind randomised controlled trial
DBT is a novel treatment for autistic adults with suicidality. It fills a significant treatment gap in lieu of any evidence-based alternative for this population. DBT reduces suicidality, enhances quality of life and is cost-effective across healthcare and societal perspectives, encouraging broader adoption. Future research should assess DBT's long-term impacts and its transferability to other countries and map pathways towards upscaled implementation.
Authors
- Mark van der Gaag (ORCID: https://orcid.org/0000-0002-3525-6415)
- Anne Huntjens (ORCID: https://orcid.org/0000-0002-0520-9212)
- Bram Sizoo (ORCID: https://orcid.org/0000-0002-9723-5716)
- L. M. C. van den Bosch (ORCID: https://orcid.org/0000-0002-6167-3589)
- Filip Smit (ORCID: https://orcid.org/0000-0001-9479-3600)
- A.J.F.M. Kerkhof (ORCID: https://orcid.org/0000-0003-1701-5332)
Institutions
- Parnassia Groep (NL)
- Dutch Expert Centre for Screening (NL)
- Amsterdam University Medical Centers (NL)
- Vrije Universiteit Amsterdam (NL)
- University of Amsterdam (NL)
- Amsterdam UMC Location Vrije Universiteit Amsterdam (NL)
Publication Details
- Journal
- The European Journal of Health Economics
- Published
- 2025-05-31
- DOI
- https://doi.org/10.1007/s10198-025-01794-3
- Primary Topic
- Autism Spectrum Disorder Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Rivierduinen
- Stichting tot Steun Vereniging tot Christelijke Verzorging van Geestes- en Zenuwzieken